Archrock [AROC] vs ChampionX [CHX] Detailed Stock Comparison
Archrock
NYSE
Loading...
ChampionX
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Archrock wins in 8 metrics, ChampionX wins in 12 metrics, with 0 ties. ChampionX appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Archrock | ChampionX | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 17.15 | 17.09 | ChampionX |
| Price-to-Book Ratio | 2.86 | 2.58 | ChampionX |
| Debt-to-Equity Ratio | 171.13 | 34.38 | ChampionX |
| PEG Ratio | 15.73 | 13.04 | ChampionX |
| EV/EBITDA | 9.11 | 6.40 | ChampionX |
| Profit Margin (TTM) | 17.17% | 8.20% | Archrock |
| Operating Margin (TTM) | 35.95% | 14.42% | Archrock |
| EBITDA Margin (TTM) | 35.95% | 14.42% | Archrock |
| Return on Equity | 12.84% | 16.83% | ChampionX |
| Return on Assets (TTM) | 4.44% | 9.44% | ChampionX |
| Free Cash Flow (TTM) | $70.56M | $448.37M | ChampionX |
| Dividend Yield | 2.12% | 1.90% | Archrock |
| 1-Year Return | 22.65% | -26.45% | Archrock |
| Price-to-Sales Ratio (TTM) | 2.97 | 1.38 | ChampionX |
| Enterprise Value | $6.30B | $4.87B | Archrock |
| EV/Revenue Ratio | 4.67 | 1.36 | ChampionX |
| Gross Profit Margin (TTM) | 45.41% | 33.72% | Archrock |
| Revenue per Share (TTM) | $8 | $19 | ChampionX |
| Earnings per Share (Diluted) | $1.33 | $1.51 | ChampionX |
| Beta (Stock Volatility) | 1.07 | 1.51 | Archrock |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Archrock vs ChampionX Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Archrock | 1.66% | 3.29% | -3.37% | -4.68% | -18.87% | -8.26% |
| ChampionX | 0.00% | -3.04% | -2.23% | 4.54% | -11.46% | -5.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Archrock | 22.65% | 191.83% | 223.54% | -0.77% | 5.07% | -69.88% |
| ChampionX | -26.45% | 32.97% | 166.63% | -32.08% | -32.08% | -32.08% |
Performance & Financial Health Analysis: Archrock vs ChampionX
| Metric | AROC | CHX |
|---|---|---|
| Market Information | ||
| Market Cap | $4.01B | $4.94B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,814,880 | 2,539,777 |
| 90 Day Avg. Volume | 1,605,367 | 2,969,606 |
| Last Close | $23.22 | $25.81 |
| 52 Week Range | $18.38 - $30.44 | $21.92 - $35.94 |
| % from 52W High | -23.72% | -28.19% |
| All-Time High | $92.75 (Oct 08, 2007) | $46.11 (May 21, 2018) |
| % from All-Time High | -74.96% | -44.03% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.42% | -0.06% |
| Quarterly Earnings Growth | 0.84% | -0.24% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.08% |
| Operating Margin (TTM) | 0.36% | 0.14% |
| Return on Equity (TTM) | 0.13% | 0.17% |
| Debt to Equity (MRQ) | 171.13 | 34.38 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.98 | $10.01 |
| Cash per Share (MRQ) | $0.03 | $2.75 |
| Operating Cash Flow (TTM) | $431.20M | $482.98M |
| Levered Free Cash Flow (TTM) | $169.95M | $252.59M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.12% | 1.90% |
| Last 12-Month Dividend | $0.53 | $0.50 |
Valuation & Enterprise Metrics Analysis: Archrock vs ChampionX
| Metric | AROC | CHX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 17.15 | 17.09 |
| Forward P/E | 15.73 | 13.04 |
| PEG Ratio | 15.73 | 13.04 |
| Price to Sales (TTM) | 2.97 | 1.38 |
| Price to Book (MRQ) | 2.86 | 2.58 |
| Market Capitalization | ||
| Market Capitalization | $4.01B | $4.94B |
| Enterprise Value | $6.30B | $4.87B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.67 | 1.36 |
| Enterprise to EBITDA | 9.11 | 6.40 |
| Risk & Other Metrics | ||
| Beta | 1.07 | 1.51 |
| Book Value per Share (MRQ) | $7.98 | $10.01 |
Financial Statements Comparison: Archrock vs ChampionX
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AROC | CHX |
|---|---|---|
| Revenue/Sales | $347.16M | $864.46M |
| Cost of Goods Sold | $182.68M | $572.94M |
| Gross Profit | $164.49M | $291.53M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $127.28M | $114.48M |
| EBITDA | $186.79M | $179.17M |
| Pre-Tax Income | $91.99M | $104.41M |
| Income Tax | $21.14M | $15.38M |
| Net Income (Profit) | $70.85M | $89.03M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AROC | CHX |
|---|---|---|
| Cash & Equivalents | $4.84M | $526.56M |
| Total Current Assets | $271.97M | $1.77B |
| Total Current Liabilities | $184.63M | $784.90M |
| Long-Term Debt | $2.31B | $633.17M |
| Total Shareholders Equity | $1.35B | $1.90B |
| Retained Earnings | $-2.40B | $-171.24M |
| Property, Plant & Equipment | $54.86M | $1.54B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AROC | CHX |
|---|---|---|
| Operating Cash Flow | $121.65M | $63.44M |
| Capital Expenditures | $2.90M | $3.00M |
| Free Cash Flow | $-52.51M | $35.55M |
| Debt Repayment | $-305.68M | $-5.38M |
| Common Stock Repurchase | $-223,000 | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | AROC | CHX |
|---|---|---|
| Shares Short | 4.88M | 4.50M |
| Short Ratio | 3.44 | 1.56 |
| Short % of Float | 0.03% | 0.03% |
| Average Daily Volume (10 Day) | 1,814,880 | 2,539,777 |
| Average Daily Volume (90 Day) | 1,605,367 | 2,969,606 |
| Shares Outstanding | 175.17M | 190.70M |
| Float Shares | 163.03M | 189.36M |
| % Held by Insiders | 0.07% | 0.01% |
| % Held by Institutions | 0.96% | 0.96% |
Dividend Analysis & Yield Comparison: Archrock vs ChampionX
| Metric | AROC | CHX |
|---|---|---|
| Last 12-Month Dividend | $0.53 | $0.50 |
| Last 12-Month Dividend Yield | 2.12% | 1.90% |
| 3-Year Avg Annual Dividend | $0.58 | $0.39 |
| 3-Year Avg Dividend Yield | 1.19% | 0.31% |
| 3-Year Total Dividends | $1.75 | $1.17 |
| Ex-Dividend Date | Feb 12, 2025 | Jul 03, 2025 |